This inventor holds 1 USPTO granted patent. Top assignees: Lek Pharmaceuticals D.d., University of Ljubljana, Faculty of Pharmacy. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 107 
1 out of 2 Years Active: 2009
Title: Unveiling the Innovations of Andreja Jurca: Pioneering Thrombin Inhibitors
Introduction: Andreja Jurca, a distinguished inventor hailing from Žiri, Slovenia, has made significant contributions to the field of pharmaceuticals through his groundbreaking work on thrombin inhibitors.
Latest Patents: Jurca has a notable patent in his name, focusing on novel thrombin inhibitors described by a specific formula and their pharmaceutical salts. These compounds have proven efficacy as thrombin inhibitors, showcasing his expertise in the realm of pharmaceutical innovation.
Career Highlights: Throughout his career, Jurca has been associated with esteemed institutions such as the University of Ljubljana, Faculty of Pharmacy, and Lek Pharmaceuticals d.d. His tenure at these institutions has been marked by a commitment to pioneering research and development in the pharmaceutical sector.
Collaborations: Jurca has had the privilege of collaborating with talented individuals in his field, including coworkers like Lucija Peterlin Marsic and Danijel Kikelj. These collaborations have fostered a culture of innovation, leading to the successful development of impactful pharmaceutical solutions.
Conclusion: Andreja Jurca's work stands as a testament to his dedication to advancing pharmaceutical innovations, particularly in the realm of thrombin inhibitors. His contributions have not only enriched the field but have also paved the way for future breakthroughs in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile